Report
22 Jun 2024
The report comprehensively describes the status of access to medicines for neurological disorders worldwide. The report offers a framework for multi-level, multi-sectoral actions, and serves as a call to action for all stakeholders to commit to tangible, sustainable improvements in the accessibility of medicines for neurological disorders.
Database
13 Jun 2024
The primary health care (PHC) country case study compendium is a global resource that aims to enhance ease of access to PHC country case studies published across WHO, international development partners and other global stakeholders. Country cases are regularly added to the compendium. See below for details on how to submit a new case. Primary health care (PHC)-oriented policies, strategies and...
Case study
29 May 2024
Background Cervical cancer remains a global health challenge. With estimated 604,000 new cases and 342,000 deaths worldwide in 2020, cervical cancer is the fourth most frequently diagnosed cancer and the fourth leading cause of death from cancer among women. Most cases and deaths occur in low- and middle-income countries (LMICs). Infection with high-risk HPV (hrHPV) types is the main risk f...
Briefs & Fact Sheets
23 May 2024
Over the past 30 years the landscape of acute stroke care has been transformed providing cost effective solutions that can save millions of lives and improve outcomes for patients. Despite this potential, globally only 3% of eligible patients have access. Time for a Revolution sets out the evidence base for, and the opportunities that exist to advance access to quality acute stroke and deliver Hea...
19 May 2024
Increasing access to treatment for people with diabetes. The MSF Access Campaign is working to improve access to treatment for people living with diabetes, by advocating for:Increased competition in the insulin marketReduced cost of the diabetes treatment 'bundle'WHO and national policies to support access to diabetes care.
Publication
10 May 2024
This document provides an updated list of “best buys” and other recommended interventions to address noncommunicable diseases (NCDs). It is based on Appendix 3 of the Global action plan for the prevention and control of noncommunicable diseases 2013–2020, which was first approved in 2013 and last updated in 2017. The global action plan, which was extended to 2030 by a World Health Assembly d...
Article
08 May 2024
Non-communicable diseases like hypertension and diabetes have emerged as serious health crises in developing countries, as HIV was a decade ago. New models of primary health care that combine NCD and HIV care are catching on – and Tanzania is implementing this approach.
Article
07 May 2024
Contemporary data on the availability, cost and affordability of essential medicines for chronic respiratory diseases (CRDs) across low-income and middle-income countries (LMICs) are missing, despite most people with CRDs living in LMICs. Cross-sectional data for seven CRD medicines in pharmacies, healthcare facilities and central medicine stores were collected from 60 LMICs in 2022–2023. Medici...
Publication
30 Apr 2024
This document provides an updated list of “best buys” and other recommended interventions to address noncommunicable diseases (NCDs). It is based on Appendix 3 of the Global action plan for the prevention and control of noncommunicable diseases 2013–2020, which was first approved in 2013 and last updated in 2017. The global action plan, which was extended to 2030 by a World Health Assembly d...
Briefs & Fact Sheets
09 Apr 2024
In 2019 a review was published on the impact of insulin donation programmes in ten low- and middle-income countries (LMIC) over the period 2009-2015. This study led to the formulation of a ten-step process for the transition from a donation-supported project towards a national diabetes programme. Tanzania has been in the process of such a transition since 2005. Despite some remaining c...
Strategy document
04 Apr 2024
Universal Health Coverage (UHC) is defined to mean that everyone, everywhere, should have access to the health services (health promotion, prevention, diagnosis, and treatment) they need without risking falling into financial hardship. UHC is a major cornerstone of the UN Sustainable Development Goals (SDGs) and is the backbone of robust health systems that are needed to deliver greater global...
Publication
04 Apr 2024
Explore how the innovative pharmaceutical industry is partnering to ensure innovation and access contribute to global health progress and improve lives everywhere in this report.The Sustainable Development Goals (SDGs) explicitly strive to engage the private sector in addressing the world’s most pressing challenges and emphasize the importance of cross-sector collaborations. Universal Health Cov...
